Coronavirus Pilot Test: First Countries And AstraZeneca Estonia To Participate In Pilot Of Guardtime’s VaccineGuard

Coronavirus pilot test: First Countries And AstraZeneca Estonia To Participate In Pilot Of Guardtime’s VaccineGuard

· The product, built on KSI technology is based on a six-month collaboration with the Estonian Government and World Health Organization

· The network is an open platform for public health authorities, hospitals, citizens, certificate providers, vaccine manufacturers, border guards, and others to securely and reliably share information across systems and borders

· The solution provides a feedback loop between all participants in the network for usage cases as diverse as counterfeit detection, vaccine allocation prioritization, and pharmacovigilance while employing leading privacy and security features to protect patient and other sensitive information

Guardtime, Europe’s leading deep tech company, has announced that, Estonia, Hungary, and Iceland are the first countries to sign-up to pilot VaccineGuard, its newly developed platform to support the global COVID-19 vaccination programme, ensuring reliable vaccines, vaccination certificate interoperability and pharmacovigilance.

AstraZeneca Estonia will participate in VaccineGuard product testing enabling an end to end solution with a feedback loop between manufacturer, care provider, citizen and public-health authorities.

The product is based on a six month collaboration with the Estonian Government and World Health Organization with additional governments expected to join the pilot network in the near future.

VaccineGuard will be the first solution adopted by national health authorities that links decision-critical data like vaccinations and authentic vaccines across multiple systems integral to the successful delivery of the COVID-19 vaccination program and enabling global travel.

Ain Aaviksoo, Chief Medical Officer, Guardtime said: “We are delighted that Iceland, Estonia, and Hungary have agreed to pilot our new platform.  These countries have been among the most proactive and most successful in developing state of the art tools and strategies for addressing Coronavirus, and we look forward to working with them on this project and sharing the findings with other countries and stakeholders to get soon back to normalcy.”

VaccineGuard will provide proof of critical data accuracy, from verifying the vaccine against authentic vaccine data repository, managing and monitoring compliance with national and local mandates on distribution and administration to priority groups for inoculation, to patient verification and eligibility, and real-time updates to health authorities, giving them better insight into the vaccination program progress and success.  It will deliver automated aggregated reports from vaccination sites, automated monitoring of stock and vaccinations, and provide the ability to facilitate adverse effect reporting, supporting investigations around this more quickly.

Guardtime is an integral part of the Estonian Government’s recent offer to WHO and its member states to share its experience and that of its key companies in healthcare digitization that use distributed information architecture and interoperability, and how this could be used in the fight against COVID-19.

Jüri Ratas, the Prime Minister of Estonia said: “The pandemic has shown the world that in crisis we need to have a global anchor of trust like the WHO. The World Health Organization can play a critical positive role in global digital health governance. Our pilot project presents an extraordinary opportunity for the Estonian community to help the world in the fight against COVID-19.”